Acquiring Company
The START Center for Cancer Research
Acquired Company
Carolina Urologic Research Center
San AntonioMyrtle BeachBiotechnologyHealth CareBiotechnologyHealth CareMedicalDescription
The START Center for Cancer Research has expanded its network by acquiring Carolina Urologic Research Center, a leader in urologic clinical trials. This acquisition will enhance START's capabilities in genitourinary oncology research. CURC's expertise will contribute significantly to START's goal of advancing clinical trials. The integration will also lead to the establishment of a dedicated Center of Excellence for urological cancers.
Quick answer
The START Center for Cancer Research is acquiring Carolina Urologic Research Center, announced March 18, 2025. The START Center for Cancer Research is based in San Antonio, Texas, United States.
- How much did The START Center for Cancer Research pay for Carolina Urologic Research Center?
- The deal value was not disclosed.
- What does The START Center for Cancer Research do?
- The START Center for Cancer Research is deeply rooted in community oncology centers globally, providing access to specialized preclinical and Phase 1 clinical trials of novel anti-cancer agents.
- Where are The START Center for Cancer Research and Carolina Urologic Research Center based?
- The START Center for Cancer Research is based in San Antonio, Texas, United States. Carolina Urologic Research Center is based in Myrtle Beach, South Carolina, United States.
- Who are the decision-makers at The START Center for Cancer Research?
- Fundz holds 1 contact at The START Center for Cancer Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Organon acquires Tofidence biosimilar rights (April 14, 2025)
- Globus Medical completes acquisition of Nevro Corp. (April 3, 2025)
- Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage (February 18, 2025)
- Basel Medical Group acquires Bethesda Medical (April 30, 2025)
- Premier Biotech acquires OraSure's testing line (April 10, 2025)
- Lupin acquires UK-based Renascience Pharma (April 3, 2025)
Who to call at The START Center for Cancer Research, and when
When The START Center for Cancer Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day The START Center for Cancer Research raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at The START Center for Cancer Research, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at The START Center for Cancer Research. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment The START Center for Cancer Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Carolina Urologic Research Center?
Carolina Urologic Research Center was acquired by The START Center for Cancer Research, based in San Antonio. The deal was reported on March 18, 2025. The START Center for Cancer Research is deeply rooted in community oncology centers globally, providing access to specialized preclinical and Phase 1 clinical trials of novel anti-cancer agents. The START Center for Cancer Research is privately held and operates in Biotechnology.
When did The START Center for Cancer Research acquire Carolina Urologic Research Center?
The START Center for Cancer Research's acquisition of Carolina Urologic Research Center was reported on March 18, 2025. The START Center for Cancer Research has expanded its network by acquiring Carolina Urologic Research Center, a leader in urologic clinical trials. This acquisition will enhance START's capabilities in genitourinary oncology research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Carolina Urologic Research Center do?
Carolina Urologic Research Center (CURC) has been recognized both nationally and internationally as one of the most progressive and respected clinical research sites in the United States. It is privately held, operating in Biotechnology, and is based in Myrtle Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.